Evidence map›Paper›PMID 35606065›Full record

ArticleThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation2022

High torque tenovirus (TTV) load before first vaccine dose is associated with poor serological response to COVID-19 vaccination in lung transplant recipients.

Rogier As Hoek, Erik Am Verschuuren, Rory D de Vries, Judith M Vonk, Debbie van Baarle, Marieke van der Heiden, Johanna P van Gemert, Edmund J Gore, Hubert Gm Niesters, Michiel Erasmus and 6 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Anellovirus-mediated interferon dysregulation enhances virus-induced lung injury.American journal of respiratory cell and molecular biology · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Assessment ofInternational journal of molecular sciences · 2025
    Article
  8. Molecular monitoring of lung allograft health: is it ready for routine clinical use?European respiratory review : an official journal of the European Respiratory Society · 2023
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. TTV viral load as a predictor of antibody response to SARS COV-2 vaccination.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2023
    Article
  17. Article
  18. Review
  19. Article
  20. Torque teno virus DNA load as a predictive marker of antibody response to a three-dose regimen of COVID-19 mRNA-based vaccine in lung transplant recipients.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Rogier As HoekDepartment of Pulmonary Medicine, University Medical Center Rotterdam, Rotterdam, the Netherlands.
Erik Am VerschuurenDepartment of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, the Netherlands.
Rory D de VriesDepartment of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands.
Judith M VonkDepartment of Epidemiology and Groningen Research Institute for Asthma and COPD (GRIAC), University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Debbie van BaarleDepartment of Medical Microbiology, University of Groningen, University Medical Center Groningen, the Netherlands; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
Marieke van der HeidenDepartment of Medical Microbiology, University of Groningen, University Medical Center Groningen, the Netherlands.
Johanna P van GemertDepartment of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, the Netherlands.
Edmund J GoreDepartment of Medical Microbiology, University of Groningen, University Medical Center Groningen, the Netherlands.
Hubert Gm NiestersDepartment of Medical Microbiology, University of Groningen, University Medical Center Groningen, the Netherlands.
Michiel ErasmusDepartment of Thoracic Surgery, University of Groningen, University Medical Center Groningen, Netherlands.
Merel E HellemonsDepartment of Pulmonary Medicine, University Medical Center Rotterdam, Rotterdam, the Netherlands.
Sandra Mj ScherbeijnDepartment of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands.
Nynke WijbengaDepartment of Pulmonary Medicine, University Medical Center Rotterdam, Rotterdam, the Netherlands.
Edris A F MahtabDepartment of Cardiothoracic Surgery, Erasmus Medical Center, Rotterdam, the Netherlands.
Corine H GeurtsvanKesselDepartment of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands.
Coretta Van Leer ButerDepartment of Medical Microbiology, University of Groningen, University Medical Center Groningen, the Netherlands. Electronic address: c.van.leer@umcg.nl.
University Medical Center Groningen · NLErasmus MC · NLRotterdam University of Applied Sciences · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSerological responses to COVID-19 vaccination are diminished in recipients of solid organ transplants, especially in lung transplant recipients (LTR), probably as result of immunosuppressive treatment. There is currently no marker of immunosuppression that can be used to predict the COVID-19 vaccination response. Here, we study whether torque tenovirus (TTV), a highly prevalent virus can be used as an indicator of immunosuppression.

methodsThe humoral response to the mRNA 1273 vaccine was assessed in 103 LTR, who received a transplant between 4 and 237 months prior to vaccination, by measuring Spike (S)-specific IgG levels at baseline, 28 days after first, and 28 days after the second vaccination. TTV loads were determined by RT-PCR and Pearson's correlation coefficient was calculated to correlate serological responses to TTV load.

resultsHumoral responses to COVID-19 vaccination were observed in 41 of 103 (40%) LTR at 28 days after the second vaccination. Sixty-two of 103 (60%) were non-responders. Lower TTV loads at baseline (significantly) correlated with higher S-specific antibodies and a higher percentage of responders. Lower TTV loads also strongly correlated with longer time since transplantation, indicating that participants with lower TTV loads were longer after transplantation.

conclusionsThis study shows a better humoral response to the SARS-CoV-2 vaccine in subjects with a lower TTV load pre-vaccination. In addition, TTV load correlates with the time after transplantation. Further studies on the use of TTV load in vaccination efficacy studies in immunocompromised cohorts should provide leads for the potential use of this marker for optimizing vaccination response.

Indexed as

COVID-19Torque teno virus2019-nCoV Vaccine mRNA-1273COVID-19 VaccinesHumansLungSARS-CoV-2TorqueTransplant RecipientsVaccination2019-nCoV Vaccine mRNA-1273COVID-19 VaccinesCOVID-19lung transplantationtorque tenovirusTTVvaccination response

Identifiers

PMID35606065
PMCPMC8924026
OpenAlexW4282921636

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.